Trial Profile
Effect of rosiglitazone treatment on acid-labile subunit expression in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2015
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 30 Jan 2015 New trial record